- Home
- WST vs LH Comparison
WST vs LH Comparison
Compare WST & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- LH
- Stock Information
- Founded
- WST 1923
- LH 1971
- Country
- WST United States
- LH United States
- Employees
- WST N/A
- LH N/A
- Industry
- WST Medical/Dental Instruments
- LH Medical Specialities
- Sector
- WST Health Care
- LH Health Care
- Exchange
- WST Nasdaq
- LH Nasdaq
- Market Cap
- WST 20.1B
- LH 22.8B
- IPO Year
- WST N/A
- LH N/A
- Fundamental
- Price
- WST $299.62
- LH $280.09
- Analyst Decision
- WST Strong Buy
- LH Strong Buy
- Analyst Count
- WST 8
- LH 13
- Target Price
- WST $348.00
- LH $297.92
- AVG Volume (30 Days)
- WST 707.3K
- LH 551.0K
- Earning Date
- WST 10-23-2025
- LH 10-28-2025
- Dividend Yield
- WST 0.30%
- LH 1.03%
- EPS Growth
- WST 0.17
- LH 72.08
- EPS
- WST 6.75
- LH 9.07
- Revenue
- WST $3,017,900,000.00
- LH $13,483,800,000.00
- Revenue This Year
- WST $6.49
- LH $10.91
- Revenue Next Year
- WST $6.23
- LH $4.79
- P/E Ratio
- WST $44.06
- LH $30.83
- Revenue Growth
- WST 4.92
- LH 7.98
- 52 Week Low
- WST $187.43
- LH $209.38
- 52 Week High
- WST $352.33
- LH $293.72
- Technical
- Relative Strength Index (RSI)
- WST 72.87
- LH 50.74
- Support Level
- WST $260.12
- LH $276.00
- Resistance Level
- WST $322.34
- LH $293.72
- Average True Range (ATR)
- WST 7.39
- LH 5.62
- MACD
- WST 3.28
- LH -0.17
- Stochastic Oscillator
- WST 64.97
- LH 29.86
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.